Home / Inspections / 1208375

FDA Inspection 1208375 — Baxalta US Incorporated

Baxalta US Incorporated — FEI 2011021

The FDA completed an inspection of Baxalta US Incorporated on May 31, 2023 in Los Angeles, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 31, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Los Angeles, CA (United States)

Facility

Other inspections at this facility

  • 1287588 (NAI Fri Nov 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1072937 (VAI Fri Nov 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 998105 (VAI Tue Dec 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 923173 (VAI Fri Mar 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 801949 (VAI Thu Sep 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources